» Articles » PMID: 28004776

A20 Curtails Primary but Augments Secondary CD8 T Cell Responses in Intracellular Bacterial Infection

Overview
Journal Sci Rep
Specialty Science
Date 2016 Dec 23
PMID 28004776
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The ubiquitin-modifying enzyme A20, an important negative feedback regulator of NF-κB, impairs the expansion of tumor-specific CD8 T cells but augments the proliferation of autoimmune CD4 T cells. To study the T cell-specific function of A20 in bacterial infection, we infected T cell-specific A20 knockout (CD4-Cre A20) and control mice with Listeria monocytogenes. A20-deficient pathogen-specific CD8 T cells expanded stronger resulting in improved pathogen control at day 7 p.i. Imaging flow cytometry revealed that A20-deficient Listeria-specific CD8 T cells underwent increased apoptosis and necroptosis resulting in reduced numbers of memory CD8 T cells. In contrast, the primary CD4 T cell response was A20-independent. Upon secondary infection, the increase and function of pathogen-specific CD8 T cells, as well as pathogen control were significantly impaired in CD4-Cre A20 mice. In vitro, apoptosis and necroptosis of Listeria-specific A20-deficient CD8 T cells were strongly induced as demonstrated by increased caspase-3/7 activity, RIPK1/RIPK3 complex formation and more morphologically apoptotic and necroptotic CD8 T cells. In vitro, A20 limited CD95L and TNF-induced caspase3/7 activation. In conclusion, T cell-specific A20 limited the expansion but reduced apoptosis and necroptosis of Listeria-specific CD8 T cells, resulting in an impaired pathogen control in primary but improved clearance in secondary infection.

Citing Articles

Deubiquitinases and Cancer.

Murali P, Kavitha B, Narasimhan M J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4210-S4220.

PMID: 40061651 PMC: 11888656. DOI: 10.4103/jpbs.jpbs_517_24.


NF-κB regulated expression of A20 controls IKK dependent repression of RIPK1 induced cell death in activated T cells.

Layzell S, Barbarulo A, van Loo G, Beyaert R, Seddon B Cell Death Differ. 2024; 32(2):256-270.

PMID: 39327505 PMC: 11802744. DOI: 10.1038/s41418-024-01383-6.


Mistuned NF-κB signaling in lymphocytes: lessons from relevant inborn errors of immunity.

Dabbah-Krancher G, Snow A Clin Exp Immunol. 2023; 212(2):117-128.

PMID: 36651621 PMC: 10128170. DOI: 10.1093/cei/uxad006.


Transcriptome Profiling of Porcine Naïve, Intermediate and Terminally Differentiated CD8 T Cells.

Lagumdzic E, Pernold C, Viano M, Olgiati S, Schmitt M, Mair K Front Immunol. 2022; 13:849922.

PMID: 35265090 PMC: 8900158. DOI: 10.3389/fimmu.2022.849922.


Topical Application of Temperature-Sensitive Gel Containing Caerin 1.1 and 1.9 Peptides on TC-1 Tumour-Bearing Mice Induced High-Level Immune Response in the Tumour Microenvironment.

Ni G, Liu X, Li H, Fogarty C, Chen S, Zhang P Front Oncol. 2021; 11:754770.

PMID: 34858827 PMC: 8632150. DOI: 10.3389/fonc.2021.754770.


References
1.
Boone D, Turer E, Lee E, Ahmad R, Wheeler M, Tsui C . The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol. 2004; 5(10):1052-60. DOI: 10.1038/ni1110. View

2.
Hovelmeyer N, Reissig S, Xuan N, Adams-Quack P, Lukas D, Nikolaev A . A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies. Eur J Immunol. 2011; 41(3):595-601. DOI: 10.1002/eji.201041313. View

3.
Krueger A, Fas S, Baumann S, Krammer P . The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol Rev. 2003; 193:58-69. DOI: 10.1034/j.1600-065x.2003.00047.x. View

4.
Xuan N, Wang X, Nishanth G, Waisman A, Borucki K, Isermann B . A20 expression in dendritic cells protects mice from LPS-induced mortality. Eur J Immunol. 2014; 45(3):818-28. DOI: 10.1002/eji.201444795. View

5.
Zhang N, Bevan M . CD8(+) T cells: foot soldiers of the immune system. Immunity. 2011; 35(2):161-8. PMC: 3303224. DOI: 10.1016/j.immuni.2011.07.010. View